zofran 4mg/2ml solution for injection or infusion
novartis ireland limited - ondansetron hydrochloride dihydrate - solution for injection/infusion - 4 mg/2ml - serotonin (5ht3) antagonists; ondansetron
zofran 4 mg/5 ml syrup
novartis ireland limited - ondansetron - syrup - 4 mg/5ml - serotonin (5ht3) antagonists; ondansetron
zofran 8mg/4ml solution for injection or infusion
novartis ireland limited - ondansetron hydrochloride dihydrate - solution for injection/infusion - 8mg/4 millilitre(s) - serotonin (5ht3) antagonists; ondansetron
zofran zydis 8 mg oral lyophilisate
novartis ireland limited - ondansetron - oral lyophilisate - 8 milligram(s) - serotonin (5ht3) antagonists; ondansetron
zofran zydis 4 mg oral lyophilisate
novartis ireland limited - ondansetron - oral lyophilisate - 4 milligram(s) - serotonin (5ht3) antagonists; ondansetron
zofran zydis 4 mg oral lyophilisate
originalis b.v. - ondansetron - oral lyophilisate - 4 milligram(s) - serotonin (5ht3) antagonists; ondansetron
zofran ondansetron (as hydrochloride dihydrate) 8mg tablet bottle
aspen pharmacare australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 10 mg (equivalent: ondansetron, qty 8 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; titanium dioxide; iron oxide yellow; hypromellose - ondansetron (tablets, syrup, wafers, suppository and injection) is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy
zofran ondansetron (as hydrochloride dihydrate) 4mg tablet bottle
aspen pharmacare australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 5 mg (equivalent: ondansetron, qty 4 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; titanium dioxide; iron oxide yellow; hypromellose - ondansetron (tablets, syrup, wafers, suppository and injection) is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy
zofran ondansetron (as hydrochloride dihydrate) 24 mg tablet blister pack
aspen pharmacare australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 30 mg (equivalent: ondansetron, qty 24 mg) - tablet, film coated - excipient ingredients: lactose; microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; titanium dioxide; hypromellose; triacetin; iron oxide red - ondansetron (tablets, syrup, wafters, suppository, and injection) is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.
zofran zydis 4 mg oral lyophilisate
pco manufacturing ltd. - ondansetron - oral lyophilisate - 4 milligram(s) - ondansetron